CT
Citius Oncology, Inc. (CTOR)
NASDAQ·Healthcare·Drug Manufacturers - General
$0.70
+0.71%
Mkt Cap $77.11M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+760.3%
Consensus $6.00 vs current $0.70